Clover Health (CLOV)
Offers wide-network Medicare Advantage plans powered by point-of-care physician software.
$4.67
vs last close+0.13 (+2.88%)
In millions of USD, except per-share figures
| In millions | Q3 FY23Sep 2023 | Q4 FY23Dec 2023 | Q1 FY24Mar 2024 | Q2 FY24Jun 2024 | Q3 FY24Sep 2024 | Q4 FY24Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 306 | 510 | 347 | 356 | 331 | 337 | 462 | 478 | 497 | 488 | 749 | 743 |
| Cost of revenue | 236 | 448 | 265 | 248 | 250 | 243 | 353 | 378 | 423 | 413 | 590 | 590 |
| Gross profit | 70 | 62 | 82 | 108 | 81 | 94 | 109 | 100 | 73 | 74 | 160 | 153 |
| 104 | 128 | 104 | 101 | 90 | 115 | 110 | 110 | 98 | 124 | 132 | 125 | |
| 102 | 110 | 104 | 100 | 90 | 115 | 110 | 110 | 97 | −140 | 132 | 124 | |
| General & administrative | 102 | 110 | 104 | 100 | 90 | 115 | 110 | 110 | 97 | −140 | 132 | 124 |
| Other expenses | 2 | 18 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 264 | 1 | 1 |
| Operating income | −34 | −66 | −23 | 7 | −9 | −21 | −1 | −11 | −24 | −49 | 27 | 28 |
| 0 | −5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Other non-operating income | 0 | 5 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income before tax | −34 | −70 | −23 | 7 | −9 | −21 | −1 | −11 | −24 | −49 | 27 | 28 |
| Net income from continuing operations | −34 | −70 | −23 | 7 | −9 | −21 | −1 | −11 | −24 | −49 | 27 | 28 |
| Discontinued operations | −8 | 0 | 4 | 0 | 0 | −1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income | −41 | −70 | −19 | 7 | −9 | −22 | −1 | −11 | −24 | −49 | 27 | 28 |
| EPS, basic | −$0.09 | −$0.15 | −$0.04 | $0.01 | −$0.02 | −$0.04 | −$0.00 | −$0.02 | −$0.05 | −$0.10 | $0.05 | $0.05 |
| EPS, diluted | −$0.09 | −$0.15 | −$0.04 | $0.01 | −$0.02 | −$0.04 | −$0.00 | −$0.02 | −$0.05 | −$0.10 | $0.05 | $0.05 |
| Weighted average shares, basic | 481 | 482 | 486 | 487 | 490 | 492 | 497 | 509 | 513 | 517 | 522 | 524 |
| Weighted average shares, diluted | 481 | 482 | 567 | 495 | 490 | 492 | 497 | 509 | 513 | 517 | 533 | 545 |
| EBITDA | −33 | −70 | −22 | 8 | −9 | −21 | −1 | −10 | −24 | −49 | 28 | 29 |
| Depreciation & amortization | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
| EBIT | −34 | −70 | −22 | 7 | −9 | −21 | −1 | −11 | −24 | −49 | 27 | 28 |